Human wild-type SEDL protein functionally complements yeast Trs20p but some naturally occurring SEDL mutants do not

Gene

Volumn 320, Issue 1-2, 2003, Pages 137-144

  Gécz, Jozef ^a,b   Shaw, Marie A ^a,b   Bellon, Jennifer R ^c   De Barros Lopes, Miguel ^c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c AUSTRALIAN WINE RESEARCH INSTITUTE   (Australia)

Author keywords

Bone dysplasia; Functional complementation; Spondyloepiphyseal dysplasia tarda; TRS20; X linked; Yeast model

Indexed keywords

FUNGAL PROTEIN; GENE PRODUCT; PROTEIN; PROTEIN SUBUNIT; RECOMBINANT PROTEIN; SPONDYLOEPIPHYSEAL DYSPLASIA TARDA PROTEIN; TRANSPORT PROTEIN PARTICLE SUBUNIT 20 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC COMPLEMENTATION; GENETIC CONSERVATION; KNOCKOUT GENE; LETHAL GENE; MISSENSE MUTATION; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE; SPONDYLOEPIPHYSEAL DYSPLASIA; YEAST;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; VERTEBRATA;

EID: 0242298582     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(03)00819-9     Document Type: Article

References (33)

1. Christianson T.W., Sikorski R.S., Dante M., Shero J.H., Hieter P. Multifunctional yeast high-copy-number shuttle vectors. Gene. 110:1992;119-122.
2. Christie P.T., Curley A., Nesbit M.A., Chapman C., Genet S., Harper P.S., Keeling S.L., Wilkie A.O., Winter R.M., Thakker R.V. Mutational analysis in X-linked spondyloepiphyseal dysplasia tarda. J. Clin. Endocrinol. Metab. 86:2001;3233-3236.
3. Gavin A.C.et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 415:2002;141-147.
4. Gécz J., Hillman M.A., Gedeon A.K., Cox T.C., Baker E., Mulley J.C. Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda. Genomics. 69:2000;242-251.
5. Gedeon A.K., Colley A., Jamieson R., Thompson E.M., Rogers J., Sillence D., Tiller G.E., Mulley J.C., Gécz J. Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat. Genet. 22:1999;400-404.
6. Gedeon A.K., Tiller G.E., Le Merrer M., Heuertz S., Tranebjaerg L., Chitayat D., Robertson S., Glass I.A., Savarirayan R., Cole W.G.et al. The molecular basis of X-linked spondyloepiphyseal dysplasia tarda. Am. J. Hum. Genet. 68:2001;1386-1397.
7. Ghosh A.K., Majumder M., Steele R., White R.A., Ray R.B. A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1. Mol. Cell. Biol. 21(2):2001;655-662.
8. Giaever G. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 418(6896):2002;387-391.
9. Grunebaum E., Arpaia E., MacKenzie J.J., Fitzpatrick J., Ray P.N., Roifman C.M. A missense mutation in the SEDL gene results in delayed onset of X linked spondyloepiphyseal dysplasia in a large pedigree. J. Med. Genet. 38:2001;409-411.
10. Heuertz S., Nelen M., Wilkie A.O., Le Merrer M., Delrieu O., Larget-Piet L., Tranebjaerg L., Bick D., Hamel B., Van Oost B.A. The gene for spondyloepiphyseal dysplasia (SEDL) maps to Xp22 between DXS16 and DXS92. Genomics. 18:1993;100-104.
11. Heuertz S., Smahi A., Wilkie A.O., Le Merrer M., Maroteaux P., Hors-Cayla M.C. Genetic mapping of Xp22.12-p22.31, with a refined localization for spondyloepiphyseal dysplasia (SEDL). Hum. Genet. 96:1995;407-410.
12. Iceton J.A., Horne G. Spondylo-epiphyseal dysplasia tarda. The X-linked variety in three brothers. J. Bone Jt. Surg., Br. 68:1986;616-619.
13. Ito T., Chiba T., Ozawa R., Yoshida M., Hattori M., Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4569-4574.
14. Jang S.B., Kim Y.G., Cho Y.S., Suh P.G., Kim K.H., Oh B.H. Crystal structure of SEDL and its implications for a genetic disease spondyloepiphyseal dysplasia tarda. J. Biol. Chem. 277:2002;49863-49869.
15. Jiang Y., Scarpa A., Zhang L., Stone S., Feliciano E., Ferro-Novick S. A high copy suppressor screen reveals genetic interactions between BET3 and a new gene. Evidence for a novel complex in ER-to-Golgi transport. Genetics. 149:1998;833-841.
16. Matsui Y., Yasui N., Ozono K., Yamagata M., Kawabata H., Yoshikawa H. Loss of the SEDL gene product (Sedlin) causes X-linked spondyloepiphyseal dysplasia tarda: identification of a molecular defect in a Japanese family. Am. J. Med. Genet. 99:2001;328-330.
17. Mumberg D., Muller R., Funk M., Sacher M., Barrowman J., Schieltz D., Yates J.R. III, Ferro-Novick S. Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res. 22:1994;5767-5768.
18. Mumm S., Christie P.T., Finnegan P., Jones J., Dixon P.H., Pannett A.A., Harding B., Gottesman G.S., Thakker R.V., Whyte M.P. A five-base pair deletion in the sedlin gene causes spondyloepiphyseal dysplasia tarda in a six-generation Arkansas kindred. J. Clin. Endocrinol. Metab. 85:2000;3343-3347.
19. Mumm S., Zhang X., Gottesman G.S., McAlister W.H., Whyte M.P. Preonset studies of spondyloepiphyseal dysplasia tarda caused by a novel 2-base pair deletion in SEDL encoding sedlin. J. Bone Miner. Res. 16:2001;2245-2250.
20. Pearce D.A., Sherman F. A yeast model for the study of Batten disease. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6915-6918.
21. Pearce D.A., Sherman F. Investigation of Batten Disease with the Yeast Saccharomyces cerevisiae. Mol. Genet. Metab. 33:1999;316-319.
22. Sacher M., Jiang Y., Barrowman J., Scarpa A., Burston J., Zhang L., Schieltz D., Yates J.R. III, Abeliovich H., Ferro-Novick S. TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J. 17:1998;2494-2503.
23. Sacher M., Barrowman J., Schieltz D., Yates J.R. III, Ferro-Novick S. Identification and characterization of five new subunits of TRAPP. Eur. J. Cell Biol. 79:2000;71-80.
24. Sanjuan R., Leon M., Zueco J., Sentandreu R. Basic phenotypic analysis of six novel yeast genes reveals two essential genes and one which affects the growth rate. Yeast. 15:1999;351-360.
25. Savarirayan R., Thompson E., Gécz J. Spondylo-epiphyseal dysplasia tarda (SEDL MIM #313400). Eur. J. Hum. Genet. 11:2003;639-642.
26. Sherman F., Fink G.R., Hicks J.B. Laboratory Course Manual for Methods in Yeast Genetics. 1986;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Shi Y.R., Lee C.C., Hsu Y.A., Wang C.H., Tsai F.J., Gécz J., Bielby S., Sutherland G.R., Mulley J.C. A novel nonsense mutation of the sedlin gene in a family with spondyloepiphyseal dysplasia tarda. Hum. Hered. 54:2002;54-56.
28. Sprague G.F. Jr., Sacher M., Jiang Y., Barrowman J., Scarpa A., Burston J., Zhang L., Schieltz D., Yates J.R., Abeliovich H.et al. Assay of yeast mating reaction. Methods Enzymol. 194:1991;77-93.
29. Szpiro-Tapia S., Sefiani A., Guilloud-Bataille M., Heuertz S., Le Marec B., Frezal J., Maroteaux P., Hors-Cayla M.C. Spondyloepiphyseal dysplasia tarda: linkage with genetic markers from the distal short arm of the X chromosome. Hum. Genet. 81:1988;61-63.
30. Takahashi T., Takahashi I., Tsuchida S., Oyama K., Komatsu M., Saito H., Takada G. An SEDL gene mutation in a Japanese kindred of X-linked spondyloepiphyseal dysplasia tarda. Clin. Genet. 61:2002;319-320.
31. Taybi H., Lachman R.S. Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias. 4th ed. 1996;Mosby-Year Book, St. Louis.
32. Tiller G.E., Hannig V.L., Dozier D., Carrel L., Trevarthen K.C., Wilcox W.R., Mundlos S., Haines J.L., Gedeon A.K., Gécz J. A recurrent RNA-splicing mutation in the SEDL gene causes X-linked spondyloepiphyseal dysplasia tarda. Am. J. Hum. Genet. 68:2001;1398-1407.
33. Uetz P.et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 403:2000;623-627.